Oxytocin

What it is

Oxytocin is a peptide hormone of nine amino acids. The hypothalamus makes it, and the posterior pituitary releases it. It was the first peptide hormone to be made chemically, in 1953. Lab-made oxytocin has been a standard drug in childbirth care since the 1950s. In the body it triggers uterine contractions in labor. It also triggers the let-down of milk in breastfeeding. ²³

The same molecule is also a signal inside the brain. There it influences social recognition, trust, bonding and the stress response. Researchers found this second role mostly in rodents. It fuels the market for intranasal oxytocin sprays. These are sold online even though they have no approved use. ³⁴¹⁴

How it works

Neurons in two clusters of the hypothalamus make oxytocin. These are the paraventricular and supraoptic nuclei. Some of these neurons send their output to the pituitary. From there oxytocin enters the blood and reaches the uterus and breast. Others send long axons straight into forebrain regions such as the amygdala and nucleus accumbens. They release oxytocin there as a neuromodulator. The two systems can be activated separately. So blood levels of oxytocin say little about what is happening in the brain. ³⁴

In the uterus, oxytocin binds a G-protein-coupled receptor on muscle cells. This raises calcium inside the cells and produces contractions. The receptor count rises steeply late in pregnancy. That is why the same drug is weak early on and strong at term. In the brain the receptor is concentrated in the amygdala and related circuits. There oxytocin tends to reduce fear responses. Researchers debate whether a nasal spray delivers enough of the peptide to those circuits. ³¹⁴

What human research shows

In childbirth care, oxytocin clearly works. The open question is how to give it. A Cochrane review pooled nine randomized trials in 2,391 women. It compared high-dose and low-dose infusion regimens for inducing labor at term. High-dose regimens did not increase vaginal births within 24 hours. They did not reduce cesarean rates. They did increase uterine hyperstimulation. The trial quality was moderate, with a moderate to high risk of bias. ¹

For anxiety and depression, a 2019 systematic review found 15 randomized controlled trials. Most tested a single dose in social anxiety, phobia, major depression or postnatal depression. The review found no significant effect on core symptoms. A meta-analysis of lab stress studies looked at cortisol. It found that intranasal oxytocin had a small effect. The effect depended on how strongly the task activated the stress system. It also depended on whether participants had a psychiatric diagnosis. ⁵⁶

In PTSD, a crossover brain-imaging study looked at 37 police officers with PTSD. It also looked at 40 colleagues who had faced trauma. One dose by nose shifted amygdala links toward the pattern seen in the controls. A prevention trial then randomized 120 emergency room patients in acute distress. They got eight days of oxytocin spray or placebo soon after trauma. At the main 1.5-month check, PTSD symptoms did not differ. But a subgroup with severe early symptoms did better on oxytocin. A systematic review covered 14 studies of oxytocin sprays in PTSD. It found tentative evidence of safety but mixed evidence of benefit. Samples were small throughout. ⁷⁸⁹

For pain, a crossover study in 37 pain-free adults found that a single intranasal dose reduced cold-water pain ratings. But most participants could tell which spray they had received. A crossover imaging study included 22 men with chronic low back pain and 22 healthy men. Oxytocin lowered ratings of experimental heat pain in the patients. It had no effect on their ongoing back pain. A 2023 meta-analysis pooled the controlled data. It found no significant effect on pain. The confidence interval was wide, from only 95 participants across three studies. The authors described the field as at equipoise. ¹⁰¹¹¹²

On sexual function, a 2021 systematic review of 13 studies found that blood oxytocin tends to rise at orgasm or ejaculation. That shows oxytocin is released during sex. It does not show that giving extra oxytocin improves sex. The review did not include intervention trials. ¹⁵

Safety

As a childbirth drug, oxytocin has well-documented risks. Excessive uterine contractions can stress the fetus. The uterus can rupture in women with prior surgery. Long infusions can cause water retention and low sodium. Postpartum hemorrhage can occur when the uterus stops responding. The boxed warning against elective induction reflects the FDA's judgment. Inducing labor without a medical reason does not offer benefits that outweigh these risks. ²¹³

In trials, intranasal oxytocin has been well tolerated over short courses. Nasal irritation and headache were the main complaints. No one knows the effect of repeated use over months. No one knows the effect in people with conditions the trials excluded. Sprays sold online are unregulated. So the dose and purity of what is in the bottle are also unknown. ⁸⁹¹⁴